Sumitomo Pharma Co Ltd
DUS:DPM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sumitomo Pharma Co Ltd
DUS:DPM
|
JP |
|
BNP Paribas SA
F:BNPH
|
FR |
|
I
|
Interpublic Group of Companies Inc
F:IPG
|
US |
|
D
|
Darden Restaurants Inc
SWB:DDN
|
US |
Wall St Price Targets
DPM Price Targets Summary
Sumitomo Pharma Co Ltd
According to Wall Street analysts, the average 1-year price target for DPM is 10.76 EUR with a low forecast of 7.67 EUR and a high forecast of 14.36 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DPM's stock price target?
Price Target
10.76
EUR
According to Wall Street analysts, the average 1-year price target for DPM is 10.76 EUR with a low forecast of 7.67 EUR and a high forecast of 14.36 EUR.
What is the Revenue forecast for Sumitomo Pharma Co Ltd?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 3 years is 11%.
What is the Gross Profit forecast for Sumitomo Pharma Co Ltd?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 3 years is 13%.
What is the Operating Income forecast for Sumitomo Pharma Co Ltd?
Projected CAGR
-26%
Over the last 13 years, the compound annual growth rate for Operating Income has been -1%. The projected CAGR for the next 2 years is -26%.
What is the Pre-Tax Income forecast for Sumitomo Pharma Co Ltd?
Projected CAGR
84%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 3 years is 84%.
What is the Net Income forecast for Sumitomo Pharma Co Ltd?
Projected CAGR
48%
Over the last 13 years, the compound annual growth rate for Net Income has been 8%. The projected CAGR for the next 3 years is 48%.
